Ocupress  (U.S.N.L.M.)
Dosing 1 drop bid
Chem Specs carteolol HCL 1%
Quantities 5, 10, 15ml
Cost 26.00/5ml
Class Nonselective beta blocker, intrinsic sympathomimetic activity.
Action Reduces aqueous humor production.
Usage Indicated for lowering IOP with chronic open-angle glaucoma or ocular hypertension.
May be used concomitantly with pilocarpine and other miotics, and/or epinephrine
or dipivefrin, and/or systemically administered carbonic anhydrase inhibitors.
May be used concomitantly with pilocarpine and other miotics, and/or epinephrine or dipivefrin, and/or systemically administered carbonic anhydrase inhibitors.
Contraindications Bronchial asthma, severe COPD, sinus bradycardia; second and third-degree
atrioventricular block; overt cardiac failure; cardiogenic shock; or hypersensitivity
to any component.
Bronchial asthma, severe COPD, sinus bradycardia; second and third-degree atrioventricular block; overt cardiac failure; cardiogenic shock; or hypersensitivity to any component.
Pediatric use Safety and effectiveness in pediatric patients have not been established.
Pregnancy Category C. Teratogenic in rats but not mice at 200 times the maximum human dose.
Carteolol may affect heart rate and cholesterol less than other beta-blockers.
Does not cross blood brain-barrier so may avoid depression side effect.
BAK preserved.
Carteolol may affect heart rate and cholesterol less than other beta-blockers. Does not cross blood brain-barrier so may avoid depression side effect. BAK preserved.
    N.L.M. DailyMed page for Ocupress         PDR page for Ocupress